NewLimit
Overview Fundraising Founders & Team
Overview
Location
United States of America
Launched
2022
Category
Subcategory
--
Fundraising Round
Series A
Valuation
--
Cumulative Amount
$40M
About NewLimit
NewLimit was founded to cure aging. They are working toward this goal by uncovering sets of transcription factors that can epigenetically reprogram cells. Although its products are designed to treat aging itself, NewLimit also believe these products could treat or prevent many diseases associated with aging, including fibrosis, infectious disease, and neurodegenerative disease.
Fundraising
Series A
Date: May 16, 2023
Amount: $40M
Valuation: --
| Investors | Type | Location | Year Founded | # Portfolio Companies | Email Address | Socials |
|---|---|---|---|---|---|---|
| Fund | United States of America | -- | 1 | -- | ||
| Fund | United States of America | 1972 | 15 | plans@kpcb.com | ||
| Fund | United States of America | 2005 | 37 | submissions@foundersfund.com | ||
| Angel Investor | -- | -- | 2 | -- | ||
| Angel Investor | United States of America | -- | 7 | -- |
Founders & Team
Brian Armstrong
Greg Johnson
Jacob Kimmel
Disclaimer: This page showcases the projects or companies that have secured angel funding from various investors (corporations, funds, individuals, etc.). Most of these projects or companies are related to blockchain, but some also involve other fields like metaverse, artificial intelligence, etc. Being listed on this page does not imply that these projects or companies have issued or will issue any coins or tokens in the future.